Alarcon Tomas, Ana http://orcid.org/0000-0002-6290-1061
Fein, Joshua A. http://orcid.org/0000-0001-5441-1516
Fried, Shalev http://orcid.org/0000-0003-1306-222X
Flynn, Jessica R.
Devlin, Sean M.
Fingrut, Warren B.
Anagnostou, Theodora
Alperovich, Anna
Shah, Nishi
Fraint, Ellen http://orcid.org/0000-0001-5548-0206
Lin, Richard J. http://orcid.org/0000-0002-0834-7880
Scordo, Michael
Batlevi, Connie Lee http://orcid.org/0000-0002-9036-9463
Besser, Michal J.
Dahi, Parastoo B. http://orcid.org/0000-0002-0794-3226
Danylesko, Ivetta
Giralt, Sergio http://orcid.org/0000-0003-1944-5053
Imber, Brandon S.
Jacoby, Elad http://orcid.org/0000-0003-1411-8942
Kedmi, Meirav
Nagler, Arnon
Palomba, M. Lia http://orcid.org/0000-0001-5099-9156
Roshal, Mikhail
Salles, Gilles A.
Sauter, Craig
Shem-Tov, Noga
Shimoni, Avichai http://orcid.org/0000-0001-8782-6160
Yahalom, Joachim
Yerushalmi, Ronit
Shah, Gunjan L. http://orcid.org/0000-0002-9977-0456
Avigdor, Abraham
Perales, Miguel-Angel http://orcid.org/0000-0002-5910-4571
Shouval, Roni http://orcid.org/0000-0001-9827-8032
Article History
Received: 3 July 2022
Revised: 13 October 2022
Accepted: 18 October 2022
First Online: 5 November 2022
Competing interests
: RS: Medexus, Consultancy; PBD: Kite/Gilead, Advisory board; SAG: Actinnum, Membership on an entity’s Board of Directors or advisory committees; CELGENE, Membership on an entity’s Board of Directors or advisory committees; BMS., Membership on an entity’s Board of Directors or advisory committees; SANOFI, Membership on an entity’s Board of Directors or advisory committees; AMGEN, Membership on an entity’s Board of Directors or advisory committees; PFIZER, Membership on an entity’s Board of Directors or advisory committees; JENSENN, Membership on an entity’s Board of Directors or advisory committees; GSK., Membership on an entity’s Board of Directors or advisory committees; JAZZ, Membership on an entity’s Board of Directors or advisory committees; GAS: AbbVie Inc, Allogene Therapeutics, Autolus Therapeutics, BeiGene Ltd, Bristol-Myers Squibb Company, Celgene Corporation, Debiopharm Group, Genmab, Kite, A Gilead Company, Incyte Corporation, Janssen Biotech Inc, Miltenyi Biotec, MorphoSys, Novartis, Roche, Advisory Committee; Bristol-Myers Squibb Company, Celgene Corporation, Debiopharm Group, Genmab, Kite, A Gilead Company, Incyte Corporation, Miltenyi Biotec, MorphoSys, Novartis, Roche Laboratories Inc, Consultancy; CSS: Juno Therapeutics, Consultancy and Research Funding; Sanofi-Genzyme, Consultancy and Research Funding; Spectrum Pharmaceuticals, Consultancy; Novartis, Consultancy; Genmab, Consultancy; Precision Biosciences, Consultancy; Kite/Gilead, Consultancy; Celgene, Consultancy and Research Funding; Gamida Cell, Consultancy; GSK., Consultancy; Bristol-Myers Squibb, Research Funding; MS: McKinsey & Company, Consultancy; Angiocrine Bioscience, Consultancy and Research Funding; Omeros Corporation, Consultancy and research funding; Amgen, Inc., Research funding; Kite - A Gilead Company, Advisory Board; i3 Health, Other: Honorarium, CME activity; Medscape, LLC, Other: Honorarium, CME activity; GS: Amgen, Research Funding; Janssen Pharmaceutica, Research Funding; AA: Takeda, Consultancy and honoraria; Janseen, Research Funding; BMS, Research Funding; Gilead, Consultancy and honoraria; Pfizer, Consultancy and honoraria; M-AP: Bristol-Myers Squibb, Honoraria; Celgene, Honoraria; Equilium, Honoraria; Incyte, Honoraria and Other: Clinical trial support to institution; Karyopharm, Honoraria; Kite/Gilead, Honoraria and Other: Clinical trial support to institution; Merck, Honoraria; Miltenyi Biotec, Honoraria and Other; MorphoSys, Honoraria; Novartis, Honoraria and Other: Clinical trial support to institution; Nektar Therapeutics, Honoraria and Other; Omeros, Honoraria; Takeda, Honoraria; Cidara Therapeutics, Honoraria; Medigene, Honoraria; Sellas Life Sciences, Honoraria; Servier, Honoraria; NexImmune, Honoraria; EJ: Novartis, Advisory board, Honoraria; JY: Convergent R.N.R Ltd., Advisory board; MR: Celgene, Provision of Services; Auron Therapeutics, Inc., Ownership/Equity Interests; Provision of Services; Physicians’ Education Resourc, Provision of Services. M.J.B. Envizion Medical, Membership on an entity’s Board of Directors or advisory committees; Biological Industries (a Sartorius Company), Gilboa Therapeutics, Consultancy; Envizion Medical, Other: Patents.